Treatment

BNT324, BNT325/DB-1305, BNT327 clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedTherapeutic exploratory (Phase II)
A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors
This study is testing new combinations of medicines (DB-1311 with BNT327 or DB-1305) for people with several types of advanced cancer. It aims to see how safe the treatments are and if they can shrink tumours, helping us find better ways to fight cancer.
For: Non-small cell lung cancer (NSCLC), Cervical cancer (CC), Melanoma, Hepatocellular carcinoma (HCC), Ovarian cancer (OC), Squamous cell carcinoma of head and neck
Italy · Poland · France